Sterling Biotech gets nod for conversion price of Bonds due 2018

21 Nov 2013 Evaluate

Sterling Biotech’s existing Bond Holders at its meeting held on November 20, 2013, have approved for the conversion price of the Bonds, due 2018 to be at Rs. 60 per share, subject to Reserve Bank of India, Foreign Investment Promotion Board and such other regulatory approvals, if any, as may be required;  

The Bond holders have also approved to suspend all litigations in India and UK till January 2014 and to withdraw the litigations in India and UK on completion of the exchange and substitution of the Existing Bonds with and for the Zero Coupon Convertible Bonds due 2018.

Sterling Biotech is largest producer of pharmaceutical and nutraceutical gelatin in India and Asia as well. It has a 9.3% global market share in pharmaceutical gelatin and is among the top five gelatin producers globally.

Peers
Company Name CMP
BASF India 4039.90
Tata Chemicals 773.85
SRF 2886.20
Pidilite Inds. 1474.70
Deepak Nitrite 1565.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×